Workflow
浙江海正生物材料股份有限公司2025年半年度报告摘要

Group 1 - The company has adjusted the maximum repurchase price from 12 RMB per share to 17 RMB per share and extended the implementation period by 6 months, now ending on February 27, 2026 [16][21][36] - The repurchase plan aims to use self-owned funds and may include special loans for stock repurchase [19][20] - As of the disclosure date, the company has repurchased 1,482,364 shares, accounting for 0.731% of the total share capital, with a total expenditure of approximately 14.29 million RMB [20][21] Group 2 - The company raised a total of 845.17 million RMB from the public offering, with a net amount of 750.86 million RMB after deducting various fees [2][4] - The company has established a management system for the raised funds, ensuring they are stored in dedicated accounts and used according to regulatory requirements [4][5] - The company has not encountered any abnormal situations regarding the investment projects funded by the raised capital [7][8]